Switch theme
Sign up to access all valuation multiples
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from animal feed to medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
2022
28.2K+
LTM Revenue $14.5B
LTM EBITDA $2.5B
$31.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
DSM Firmenich has a last 12-month revenue (LTM) of $14.5B and a last 12-month EBITDA of $2.5B.
In the most recent fiscal year, DSM Firmenich achieved revenue of $14.4B and an EBITDA of $2.0B.
DSM Firmenich expects next 12-month revenue of XXX and NTM EBITDA of XXX
See DSM Firmenich valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $14.5B | XXX | $14.4B | XXX | XXX | XXX |
| Gross Profit | $4.8B | XXX | $4.8B | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $2.5B | XXX | $2.0B | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $1.3B | XXX | $605M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $579M | XXX | $281M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, DSM Firmenich's stock price is EUR 98 (or $110).
DSM Firmenich has current market cap of EUR 25.8B (or $29.0B), and EV of EUR 28.4B (or $31.9B).
See DSM Firmenich trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $31.9B | $29.0B | XXX | XXX | XXX | XXX | $3.99 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, DSM Firmenich has market cap of $29.0B and EV of $31.9B.
DSM Firmenich's trades at 2.2x EV/Revenue multiple, and 15.9x EV/EBITDA.
Equity research analysts estimate DSM Firmenich's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DSM Firmenich has a P/E ratio of 50.0x.
See valuation multiples for DSM Firmenich and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $29.0B | XXX | $29.0B | XXX | XXX | XXX |
| EV (current) | $31.9B | XXX | $31.9B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 12.7x | XXX | 15.9x | XXX | XXX | XXX |
| EV/EBIT | 23.8x | XXX | 52.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 50.0x | XXX | 103.2x | XXX | XXX | XXX |
| EV/FCF | 28.9x | XXX | 28.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDSM Firmenich's last 12 month revenue growth is 2%
DSM Firmenich's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
DSM Firmenich's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DSM Firmenich's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for DSM Firmenich and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 70% | XXX | XXX | XXX |
| Rule of 40 | 10% | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| Holland | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DSM Firmenich acquired XXX companies to date.
Last acquisition by DSM Firmenich was XXXXXXXX, XXXXX XXXXX XXXXXX . DSM Firmenich acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was DSM Firmenich founded? | DSM Firmenich was founded in 2022. |
| Where is DSM Firmenich headquartered? | DSM Firmenich is headquartered in Netherlands. |
| How many employees does DSM Firmenich have? | As of today, DSM Firmenich has 28.2K+ employees. |
| Is DSM Firmenich publicy listed? | Yes, DSM Firmenich is a public company listed on AMS. |
| What is the stock symbol of DSM Firmenich? | DSM Firmenich trades under DSFIR ticker. |
| When did DSM Firmenich go public? | DSM Firmenich went public in 2023. |
| Who are competitors of DSM Firmenich? | Similar companies to DSM Firmenich include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of DSM Firmenich? | DSM Firmenich's current market cap is $29.0B |
| What is the current revenue of DSM Firmenich? | DSM Firmenich's last 12 months revenue is $14.5B. |
| What is the current revenue growth of DSM Firmenich? | DSM Firmenich revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of DSM Firmenich? | Current revenue multiple of DSM Firmenich is 2.2x. |
| Is DSM Firmenich profitable? | Yes, DSM Firmenich is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of DSM Firmenich? | DSM Firmenich's last 12 months EBITDA is $2.5B. |
| What is DSM Firmenich's EBITDA margin? | DSM Firmenich's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of DSM Firmenich? | Current EBITDA multiple of DSM Firmenich is 12.7x. |
| What is the current FCF of DSM Firmenich? | DSM Firmenich's last 12 months FCF is $1.1B. |
| What is DSM Firmenich's FCF margin? | DSM Firmenich's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of DSM Firmenich? | Current FCF multiple of DSM Firmenich is 28.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
